A phase II study utilizing VP-16 and adriamycin in a randomized fashion tested the concept of synchronization of the drugs in treatment of metastatic breast cancer. Although there was a trend in median survival following the synchronized schedule, there was no significant difference in survival or progression-free intervals. The concept of synchronization was not established.
|Original language||English (US)|
|Number of pages||3|
|State||Published - 1980|
ASJC Scopus subject areas
- Cancer Research